PharPoint Research

  • Increase font size
  • Default font size
  • Decrease font size
Resources

PharPoint Research Recognized as One of the Triangle's Fastest Growing Companies

DURHAM, NC, November 18, 2011 - PharPoint Research, Inc., a leading drug development service provider offering biotechnology and pharmaceutical companies expertise in project management, clinical monitoring, data management and biostatistics services, announces that PharPoint Research was recognized by Triangle Business Journal as one of the 50 fastest growing companies in the Triangle area. The Fast 50 winners were selected and ranked based on a formula that counts revenue growth and profitability in the preceding three years (2008-2010). Art Holmes, the company’s President and CEO, commented, “This award is a testament to our company’s commitment to superb quality and client satisfaction. By focusing on these two areas, in the past 12 months we have been able to grow the company’s size by over 45% to offer even more services to better serve our clients.”

Read more...
 

PharPoint Selected for 2011 TBJ Fast 50 Award

October 18, 2011 -- The Triangle Business Journal unveiled PharPoint Research as a winner of the 2011 Fast 50 Award. This award directly reflects PharPoint’s continued growth and strength over the previous three year period which was achieved through an intense focus on providing excellent customer service and superb value add to pharmaceutical and biotechnology clients. PharPoint Research, Inc. is being recognized as one of the fastest growing privately held companies in the Raleigh-Durham area on November 15, 2011 when the Triangle Business Journal recognizes all award recipients at their annual TBJ Fast 50 Award Ceremony.

Read more...
 

PharPoint Research Expands in Research Triangle Park NC Area

Chapel Hill, NC, July 22, 2011 - PharPoint Research, Inc., a leading drug development service provider offering biotechnology and pharmaceutical companies expertise in project management, clinical monitoring, data management and biostatistics services, announces that it is expanding and has relocated their Chapel Hill, NC operations to new office space on Miami Boulevard in Durham, NC in the heart of the Research Triangle Park. “We are very excited about relocating our Chapel Hill operations to the RTP area. “ said Art Holmes, President and CEO. Mr. Holmes continued, “This relocation affords PharPoint the ability to better serve the needs of our clients and allows us to continue to strategically expand our business model.”

Read more...
 

Data Management Rescues

A large number of clinical trials are outsourced to Contract Research Organizations (CROs) each year. While the majority of these trials are successfully implemented and study results are delivered on-time and on-budget, situations arise when the study is not adequately managed by the vendor and the study must be “rescued”. The scope and type of study management deficiency needs to be assessed by the Sponsor to determine the type of remediation required. Rescue support may be as simple as adding third-party function experts to the Sponsor project team to aid in the management and oversight of the CRO, or as complex as selecting a new CRO to assume all responsibility for the study.

 

PharPoint Research to Exhibit at the 2011 Outsourcing in Clinical Trials New England

September 28-29, 2011, Boston, MA, The Boston Park Plaza Hotel & Towers

PharPoint Research will be exhibiting at "VIBpharma’s Outsourcing in Clinical Trials New England" which offers an expertly designed intelligence and networking platform to discuss the most pressing industry issues and provide practical solutions to the greatest challenges in clinical outsourcing. The event will drive highly informed decision-making, as we take part in intimate environment for the mutual benefit of vendors and sponsors. For more information please visit: Outsourcing in Clinical Trials

 

Data Standardization and Warehousing

The testing phase of Clinical Development takes years to complete and can result in clinical trial data being collected from up to 30 or 40 clinical trials. The preparation of a submission to Regulatory Agencies requires the aggregation of these clinical data into a consolidated and standardized structure.

A data warehouse is a data repository that allows for data from multiple data sources: multiple CROs, clinical laboratories, and other vendors, to be housed and subsequently standardized. Data, regardless of file type, is imported and converted into a common format (CDISC SDTM, ADaM, or sponsor defined format). A first step in this process is the development of a standardization map, which documents the relationship of the original data to the new standardized format and is based on the electronic annotated CRF for each individual clinical trial. Following the completion of the standardization map, the data are subjected to programmatic standardization. Once standardized, the data are available in a submission-ready format as well as being available for aggregate reporting. Data from multiple studies may be reviewed and queried which is invaluable when reviewing data for a given compound.

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »


Page 1 of 2